Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04713254 · ClinicalTrials.gov registry record · Phase 1
Drug Drug Interaction Study With Lu AG06466 in Young Healthy Men
A Phase 1 study, sponsored by H. Lundbeck A/S.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT04713254 is a Phase 1 study that has completed, run by H. Lundbeck A/S. The registered enrollment target is 15 participants.
The verdict
NCT04713254, a Phase 1 study, has completed, sponsored by H. Lundbeck A/S.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of repeated doses of the drug Lu AG06466 on the exposure of metoprolol, midazolam and bupropion
Interventions
- DRUG Lu AG06466
- OTHER Midazolam
- OTHER Metoprolol
- OTHER Bupropion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-12-08 |
| Est. Completion | 2021-04-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04713254
The ClinicalTrials.gov registry entry for NCT04713254 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lundbeck A/S, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Lu AG06466 is the first listed.
NCT04713254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04713254 about?
NCT04713254 is a clinical study titled "Drug Drug Interaction Study With Lu AG06466 in Young Healthy Men". The purpose of this study is to evaluate the effect of repeated doses of the drug Lu AG06466 on the exposure of metoprolol, midazolam and bupropion
What is the current status of trial NCT04713254?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2020-12-08. Estimated completion is 2021-04-09.
What interventions are being tested in trial NCT04713254?
The interventions under investigation include: Lu AG06466 (DRUG), Midazolam (OTHER), Metoprolol (OTHER), Bupropion (OTHER).
Who is sponsoring clinical trial NCT04713254?
This trial is sponsored by H. Lundbeck A/S, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.